ArticlePediatric dermatology
Comparing Pediatric Dermatology Research Funded by the US National Institutes of Health (NIH) With the US Skin Disease Burden in Patients Under 20 Years Old.
Article in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDisease burden, measured by disability-adjusted life years (DALYs), is a helpful metric to guide research funding priorities. Pediatric dermatologic conditions significantly contribute to DALYs, yet it is unclear whether NIH funding reflects this burden.
objectivesTo compare NIH-funded dermatology research with the most burdensome skin diseases in the United States for patients under 20 years old, as measured by DALYs, and to identify mismatches between funding and disease burden.
methodsA cross-sectional analysis was independently performed by two researchers who matched projects from the 2024 to 2025 NIH Research Portfolio Online Reporting Tools with 10 pediatric dermatology skin conditions and their respective DALYs from the Global Burden of Disease (GBD) 2021 study. NIH-funded research projects were categorized by condition and pediatric focus, and funding allocation was compared to DALYs to evaluate alignment.
resultsThe NIH supported 307 grants totaling $388 million across the 10 skin conditions. Atopic dermatitis received the most funding ($62.99 million), with 47.9% of grants pediatric-focused. Viral skin diseases, despite being second in burden, received only $2.35 million and 0 pediatric grants. Most conditions had fewer than 15% pediatric-focused grants.
conclusionsThere is a persistent mismatch between NIH funding and the burden of pediatric skin disease, both in overall funding and in the proportion of research focused on pediatric populations. Increased investment in high-burden, underfunded conditions, particularly those lacking pediatric-specific research, is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.